Sedation & Immunomodulation

Critical Care Clinics

Volumn 25, Issue 3, 2009, Pages 551-570

  Sanders, Robert D ^a,b   Hussell, Tracy ^b   Maze, Mervyn ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Benzodiazepine; Dexmedetomidine; Infection; Morphine; Propofol; Sepsis

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BENZODIAZEPINE DERIVATIVE; DEXMEDETOMIDINE; DIAZEPAM; FOSPROPOFOL; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; INTRALIPID; MITOGEN ACTIVATED PROTEIN KINASE; MORPHINE; NITRIC OXIDE SYNTHASE; OPIATE; PROPOFOL; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; CYTOKINE RELEASE; ESCHERICHIA COLI; HOST RESISTANCE; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOMODULATION; INFECTION RESISTANCE; INHIBITION KINETICS; INNATE IMMUNITY; KLEBSIELLA PNEUMONIAE; LISTERIA MONOCYTOGENES; LYMPHOCYTE PROLIFERATION; MEDICAL DECISION MAKING; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; SALMONELLA ENTERICA; SALMONELLA ENTERITIDIS; SALMONELLA TYPHIMURIUM; SEDATION; SEPSIS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; TOXOPLASMA GONDII;

ANALGESICS; CRITICAL CARE; HUMANS; HYPNOTICS AND SEDATIVES; IMMUNE SYSTEM; IMMUNOLOGIC FACTORS; NEUROIMMUNOMODULATION;

EID: 67649311608     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccc.2009.05.001     Document Type: Review

References (123)

1. Harrison D.A., Welch C.A., and Eddleston J.M. The epidemiology of severe sepsis in England, Wales and Northern Ireland, 1996 to 2004: secondary analysis of a high quality clinical database, the ICNARC Case Mix Programme Database. Crit Care 10 2 (2006) R42
2. Angus D.C., Linde-Zwirble W.T., Lidicker J., et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29 (2001) 1303-1310
3. Hotchkiss R.S., and Nicholson D.W. Apoptosis and caspases regulate death and inflammation in sepsis. Nat Rev Immunol 6 11 (2006) 813-822
4. Matute-Bello G., Frevert C.W., and Martin T.R. Animal models of acute lung injury. Am J Physiol Lung Cell Mol Physiol 295 3 (2008) L379-L399
5. Wan L., Bagshaw S.M., Langenberg C., et al. Pathophysiology of septic acute kidney injury: what do we really know?. Crit Care Med 36 4 Suppl (2008) S198-S203
6. MacDonald A., Adamis D., Treloar A., et al. C-reactive protein levels predict the incidence of delirium and recovery from it. Age Ageing 36 (2007) 222-225
7. Annane D., Bellisant E., and Cavaillon J.M. Septic shock. Lancet 365 (2005) 63-78
8. Pandharipande P.P., Sanders R.D., Girard T., et al. Comparison of sedation with dexmedetomidine versus lorazepam in septic ICU patients. Critical Care (2008) 12:P275
9. Pandharipande P.P., Pun B.T., Herr D.L., et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients. The MENDS randomized controlled trial. JAMA 298 (2007) 2644-2653
10. Nelson L.E., Lu J., Guo T., et al. The alpha2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects. Anesthesiology 98 (2003) 428-436
11. Sanders R.D., and Maze M. Alpha2-adrenoceptor agonists. Curr Opin Investig Drugs 8 (2007) 25-33
12. Smith I.M., Kennedy L.R., Regné-Karlsson M.H., et al. Adrenergic mechanisms in infection. III. Alpha- and beta-receptor blocking agents in treatment. Am J Clin Nutr 30 8 (1977) 1285-1288
13. Nance D.M., and Sanders V.M. Autonomic innervation and regulation of the immune system (1987-2007). Brain Behav Immun 21 6 (2007) 736-745
14. Heine J., Leuwer M., Scheinichen D., et al. Flow cytometry evaluation of the in vitro influence of four i.v. anaesthetics on respiratory burst of neutrophils. Br J Anaesth 77 (1996) 387-392
15. Kelbel I., and Weiss M. Anaesthetics and immune function. Curr Opin Anaesthesiol 14 6 (2001) 685-691
16. Mikawa K., Akamatsu H., Nishina K., et al. Propofol inhibits human neutrophil functions. Anesth Analg 87 (1998) 695-700
17. Corcoran T.B., Engel A., Sakamoto H., et al. The effects of propofol on neutrophil function, lipid peroxidation and inflammatory response during elective coronary artery bypass grafting in patients with impaired ventricular function. Br J Anaesth 97 6 (2006) 825-831
18. Heller A., Heller S., Blecken S., et al. Effects of intravenous anesthetics on bacterial elimination in human blood in vitro. Acta Anaesthesiol Scand 42 (1998) 518-526
19. Krumholz W., Endrass J., and Hempelmann G. Propofol inhibits phagocytosis and killing of Staphylococcus aureus and Escherichia coli by polymorphonuclear leukocytes in vitro. Can J Anaesth 41 (1994) 446-449
20. Chen R.M., Wu C.H., Chang H.C., et al. Propofol suppresses macrophage functions and modulates mitochondrial membrane potential and cellular adenosine triphosphate synthesis. Anesthesiology 98 (2003) 1178-1185
21. Chang H., Tsai S.Y., Chang Y., et al. Therapeutic concentration of propofol protects mouse macrophages from nitric oxide-induced cell death and apoptosis. Can J Anaesth 49 (2002) 477-480
22. Chen R.M., Wu G.J., Tai Y.T., et al. Propofol reduces nitric oxide biosynthesis in lipopolysaccharide-activated macrophages by downregulating the expression of inducible nitric oxide synthase. Arch Toxicol 77 (2003) 418-423
23. Chen R.M., Chen T.G., Chen T.L., et al. Anti-inflammatory and antioxidative effects of propofol on lipopolysaccharide-activated macrophages. Ann N Y Acad Sci 1042 (2005) 262-271
24. Kotani N., Hashimoto H., Sessler D.I., et al. Expression of genes for proinflammatory cytokines in alveolar macrophages during propofol and isoflurane anesthesia. Anesth Analg 89 5 (1999) 1250-1256
25. Ploppa A., Kiefer R.T., Nohe B., et al. Dose-dependent influence of barbiturates but not of propofol on human leukocyte phagocytosis of viable Staphylococcus aureus. Crit Care Med 34 2 (2006) 478-483
26. Huettemann E., Jung A., Vogelsang H., et al. Effects of propofol vs. methohexital on neutrophil function and immune status in critically ill patients. J Anesth 20 2 (2006) 86-91
27. Heine J., Jaeger K., Osthaus A., et al. Anaesthesia with propofol decreases FMLP-induced neutrophil respiratory burst but not phagocytosis compared with isoflurane. Br J Anaesth 85 (2000) 424-430
28. Inada T., Taniuchi S., Shingu K., et al. Propofol depressed neutrophil hydrogen peroxide production more than midazolam, whereas adhesion molecule expression was minimally affected by both anesthetics in rats with abdominal sepsis. Anesth Analg 92 2 (2001) 437-441
29. Galley H.F., Dubbels A.M., and Webster N.R. The effect of midazolam and propofol on interleukin-8 from human polymorphonuclear leukocytes. Anesth Analg 86 6 (1998) 1289-1293
30. O'Donnell N.G., McSharry C.P., Wilkinson P.C., et al. Comparison of the inhibitory effects of propofol, thiopentone and midazolam on neutrophil polarization in vitro in the presence or absence of human serum albumin. Br J Anaesth 69 (1992) 70-74
31. Nagata T., Kansha M., Irita K., et al. Propofol inhibits FMLP-stimulated phosphorylation of p42 mitogen-activated protein kinase and chemotaxis in human neutrophils. Br J Anaesth 86 (2001) 853-858
32. Inada T., Yamanouchi Y., Jomura S., et al. Effect of propofol and isoflurane anaesthesia on the immune response to surgery. Anaesthesia 59 (2004) 954-959
33. Pirttikangas C.O., Salo M., Mansikka M., et al. The influence of anaesthetic technique upon the immune response to hysterectomy. A comparison of propofol infusion and isoflurane. Anaesthesia 50 (1995) 1056-1061
34. Devlin E.G., Clarke R.S., Mirakhur R.K., et al. Effect of four i.v. induction agents on T-lymphocyte proliferations to PHA in vitro. Br J Anaesth 73 3 (1994) 315-317
35. Mozrzymas J.W., Teisseyre A., and Vittur F. Propofol blocks voltage-gated potassium channels in human T lymphocytes. Biochem Pharmacol 52 6 (1996) 843-849
36. Song H.K., and Jeong D.C. The effect of propofol on cytotoxicity and apoptosis of lipopolysaccharide-treated mononuclear cells and lymphocytes. Anesth Analg 98 (2004) 1724-1728
37. Taniguchi T., Yamamoto K., Ohmoto N., et al. Effects of propofol on hemodynamic and inflammatory responses to endotoxemia in rats. Crit Care Med 28 4 (2000) 1101-1106
38. Taniguchi T., Kanakura H., and Yamamoto K. Effects of posttreatment with propofol on mortality and cytokine responses to endotoxin-induced shock in rats. Crit Care Med 30 4 (2002) 904-907
39. Takemoto Y. Dose effects of propofol on hemodynamic and cytokine responses to endotoxemia in rats. J Anesth 19 1 (2005) 40-44
40. Hsu B.G., Yang F.L., Lee R.P., et al. Effects of post-treatment with low-dose propofol on inflammatory responses to lipopolysaccharide-induced shock in conscious rats. Clin Exp Pharmacol Physiol 32 1-2 (2005) 24-29
41. Kelbel I., Koch T., Weber A., et al. Alterations of bacterial clearance induced by propofol. Acta Anaesthesiol Scand 43 1 (1999) 71-76
42. Helmy S.A., and Al-Attiyah R.J. The immunomodulatory effects of prolonged intravenous infusion of propofol versus midazolam in critically ill surgical patients. Anaesthesia 56 1 (2001) 4-8
43. Kim S.N., Son S.C., Lee S.M., et al. Midazolam inhibits proinflammatory mediators in the lipopolysaccharide-activated macrophage. Anesthesiology 105 1 (2006) 105-110
44. Massoco C., and Palermo-Neto J. Effects of midazolam on equine innate immune response: a flow cytometric study. Vet Immunol Immunopathol 95 1-2 (2003) 11-19
45. Matsumoto T., Ogata M., Koga K., et al. Effect of peripheral benzodiazepine receptor ligands on lipopolysaccharide-induced tumor necrosis factor activity in thioglycolate-treated mice. Antimicrob Agents Chemother 38 4 (1994) 812-816
46. Galdiero F., Bentivoglio C., Nuzzo I., et al. Effects of benzodiazepines on immunodeficiency and resistance in mice. Life Sci 57 26 (1995) 2413-2423
47. da Silva F.R., Lazzarini R., de Sá-Rocha L.C., et al. Effects of acute and long-term diazepam administrations on neutrophil activity: a flow cytometric study. Eur J Pharmacol 478 2-3 (2003) 97-104
48. Mühling J., Sablotzki A., Fuchs M., et al. Effects of diazepam on neutrophil (PMN) free amino acid profiles and immune functions in vitro. Metabolical and immunological consequences of L-alanyl-L-glutamine supplementation. J Nutr Biochem 12 1 (2001) 46-54
49. Weiss M., Mirow N., Birkhahn A., et al. Benzodiazepines and their solvents influence neutrophil granulocyte function. Br J Anaesth 70 3 (1993) 317-321
50. Finnerty M., Marczynski T.J., Amirault H.J., et al. Benzodiazepines inhibit neutrophil chemotaxis and superoxide production in a stimulus dependent manner; PK-11195 antagonizes these effects. Immunopharmacology 22 3 (1991) 185-193
51. Laschi A., Descotes J., Tachon P., et al. Adverse influence of diazepam upon resistance to Klebsiella pneumoniae infection in mice. Toxicol Lett 16 3-4 (1983) 281-284
52. Chao C.C., Sharp B.M., Pomeroy C., et al. Lethality of morphine in mice infected with Toxoplasma gondii. J Pharmacol Exp Ther 252 (1990) 605-609
53. MacFarlane A.S., Peng X., Meissler Jr. J.J., et al. Morphine increases susceptibility to oral Salmonella typhimurium infection. J Infect Dis 181 (2000) 1350-1358
54. Asakura H., Watarai M., Shirahata T., et al. Viable but nonculturable Salmonella species recovery and systemic infection in morphine-treated mice. J Infect Dis 186 (2002) 1526-1529
55. Feng P., Truant A.L., Meissler Jr. J.J., et al. Morphine withdrawal lowers host defense to enteric bacteria: spontaneous sepsis and increased sensitivity to oral Salmonella enterica serovar Typhimurium infection. Infect Immun 74 (2006) 5221-5226
56. Wang J., Barke R.A., Charboneau R., et al. Morphine impairs host innate immune response and increases susceptibility to Streptococcus pneumoniae lung infection. J Immunol 174 (2005) 426-434
57. Wang J., Barke R.A., Charboneau R., et al. Morphine induces defects in early response of alveolar macrophages to Streptococcus pneumoniae by modulating TLR9-NF-kappa B signaling. J Immunol 180 5 (2008) 3594-3600
58. Asakura H., Kawamoto K., Igimi S., et al. Enhancement of mice susceptibility to infection with Listeria monocytogenes by the treatment of morphine. Microbiol Immunol 50 (2006) 543-547
59. Hilburger M.E., Adler M.W., Truant A.L., et al. Morphine induces sepsis in mice. J Infect Dis 176 (1997) 183-188
60. Roy S., Cain K.J., Charboneau R.G., et al. Morphine accelerates the progression of sepsis in an experimental sepsis model. Adv Exp Med Biol 437 (1998) 21-31
61. Taniguchi T., Kidani Y., Kanakura H., et al. Effects of dexmedetomidine on mortality rate and inflammatory responses to endotoxin-induced shock in rats. Crit Care Med 32 (2004) 1322-1326
62. Taniguchi T., Kurita A., Kobayashi K., et al. Dose- and time-related effects of dexmedetomidine on mortality and inflammatory responses to endotoxin-induced shock in rats. J Anesth 22 3 (2008) 221-228
63. Ugaz E.M., Pinheiro S.R., Guerra J.L., et al. Effects of prenatal diazepam treatment on Mycobacterium bovis-induced infection in hamsters. Immunopharmacology 41 3 (1999) 209-217
64. Hak E., Bont J., Hoes A.W., et al. Prognostic factors for serious morbidity and mortality from community-acquired lower respiratory tract infections among the elderly in primary care. Fam Pract 22 4 (2005) 375-380
65. Decaudin D. Peripheral benzodiazepine receptor and its clinical targeting. Anticancer Drugs 15 8 (2004) 737-745
66. Cantacuzene J. Nouvelles recherches sur le monde de destruction des vibrions dans l'organisme. Ann Inst Pasteur 12 (1898) 273-300
67. Vallejo R., de Leon-Casasola O., and Benyamin R. Opioid therapy and immunosuppression: a review. Am J Ther 11 5 (2004) 354-365
68. Roy S., Wang J., Kelschenbach J., et al. Modulation of immune function by morphine: implications for susceptibility to infection. J Neuroimmune Pharmacol 1 1 (2006) 77-89
69. Tian M., Broxmeyer H.E., Fan Y., et al. Altered hematopoiesis, behavior, and sexual function in mu opioid receptor-deficient mice. J Exp Med 185 8 (1997) 1517-1522
70. Weinert C.R., Kethireddy S., and Roy S. Opioids and infections in the intensive care unit should clinicians and patients be concerned?. J Neuroimmune Pharmacol 3 4 (2008) 218-229
71. Szabo I., Rojavin M., Bussiere J.L., et al. Suppression of peritoneal macrophage phagocytosis of Candida albicans by opioids. J Pharmacol Exp Ther 267 (1995) 703-706
72. Tubaro E., Santiangeli C., Belogi L., et al. Methadone vs morphine: comparison of their effect on phagocytic functions. Int J Immunopharmacol 9 1 (1987) 79-88
73. Tomei E.Z., and Renaud F.L. Effect of morphine on Fc-mediated phagocytosis by murine macrophages in vitro. J Neuroimmunol 74 1-2 (1997) 111-116
74. Tomassini N., Renaud F., Roy S., et al. Morphine inhibits Fc-mediated phagocytosis through μ and δ opioid receptors. J Neuroimmunol 147 1-2 (2004) 131-133
75. Choi Y., Chuang L.F., Lam K.M., et al. Inhibition of chemokine-induced chemotaxis of monkey leukocytes by mu-opioid receptor agonist. In Vivo 13 (1999) 389-396
76. Miyagi T., Chuang L.F., Lam K.M., et al. Opioid suppress chemokine-mediated migration of monkey neutrophils and monocytes - an instant response. Immunopharmacology 47 (2001) 53-62
77. Fecho K., Maslonek K.A., Coussons-Read M.E., et al. Macrophage-derived nitric oxide is involved in the depressed con A-responsiveness of splenic lymphocytes from rats administered morphine in vivo. J Immunol 152 (1994) 5845-5852
78. Pacifici R., Minetti M., Zuccaro P., et al. Morphine affects cytostatic activity of macrophages by the modulation of nitric oxide release. Int J Immunopharmacol 17 9 (1995) 771-777
79. Stefano G.B., Cadet P., Fimiani C., et al. Morphine stimulates iNOS expression via a rebound from inhibition in human macrophages: nitric oxide involvement. Int J Immunopathol Pharmacol 14 3 (2001) 129-138
80. Wang J., Charboneau R., Balasubramanian S., et al. The immunosuppressive effects of chronic morphine treatment are partially dependent on corticosterone and mediated by the mu-opioid receptor. J Leukoc Biol 71 5 (2002) 782-790
81. Sharp B.M., Keane W.F., Suh H.J., et al. Opioid peptides rapidly stimulate superoxide production by human polymorphonuclear leukocytes and macrophages. Endocrinology 117 2 (1985) 793-795
82. Bhat R.S., Bhaskaran M., Mongia A., et al. Morphine-induced macrophage apoptosis: oxidative stress and strategies for modulation. J Leukoc Biol 75 6 (2004) 1131-1138
83. Roy S., Barke R.A., and Loh H.H. Mu-receptor knockout mice: the role of mu-opioid receptor in immune functions. Brain Res Mol Brain Res 61 1-2 (1998) 190-194
84. Roy S., Charboneau R., Barke R.A., et al. Role of mu-opioid receptor in immune function. Adv Exp Med Biol 493 (2001) 117-126
85. Singhal P.C., Bhaskaran M., Patel J., et al. Role of p38 mitogen-activated protein kinase phosphorylation and Fas-Fas ligand interaction in morphine-induced macrophage apoptosis. J Immunol 168 8 (2002) 4025-4033
86. Lysle D.T., Hoffman K.E., and Dykstra L.A. Evidence for the involvement of the caudal region of the periaqueductal gray in a subset of morphine-induced alterations of immune status. J Pharmacol Exp Ther 277 (1996) 1533-1540
87. Roy S., Wang J.H., Balasubramanian S., et al. Role of hypothalamic-pituitary axis in morphine-induced alteration in thymic cell distribution using mu-opioid receptor knockout mice. J Neuroimmunol 116 2 (2001) 147-155
88. Carr D.J., and France C.P. Immune alterations in chronic morphine treated rhesus monkeys. Adv Exp Med Biol 335 (1993) 35-39
89. Wang J., Charboneau R., Balasubramanian S., et al. Morphine modulates lymph node-derived T lymphocyte function: role of caspase-3, -8, and nitric oxide. J Leukoc Biol 70 4 (2001) 527-536
90. Flores L.R., Hernandez M.C., and Bayer B.M. Acute immunosuppressive effects of morphine: lack of involvement of pituitary and adrenal factors. J Pharmacol Exp Ther 268 (1994) 1129-1134
91. Roy S., Wang J.H., Sumandeep G., et al. Chronic morphine treatment differentiates T helper cells to Th2 effector cells by modulating transcription factors GATA 3 and T bet. J Neuroimmunol 147 (2004) 78-81
92. Roy S., Wang J.H., Charboneau R.G., et al. Morphine induces CD4+ T cell IL-4 expression through an adenylyl cyclase mechanism independent of the protein kinase A pathway. J Immunol 175 10 (2005) 6361-6367
93. Avidor-Reiss T., Nevo I., Levy R., et al. Chronic opioid treatment induces adenylyl cyclase V superactivation: involvement of Gbg. J Biol Chem 271 35 (1996) 21309-21315
94. Singhal P.C., Kapasi A.A., Franki N., et al. Morphine-induced macrophage apoptosis: the role of transforming growth factor-beta. Immunology 100 1 (2000) 57-62
95. Yin D., Mufson R.A., Wang R., et al. Fas-mediated cell death promoted by opioids. Nature 397 6716 (1999) 218
96. Singhal P., Kapasi A., Reddy K., et al. Opiates promote T cell apoptosis through JNK and caspase pathway. Adv Exp Med Biol 493 (2001) 127-135
97. Bayer B.M., Daussin S., Hernandez M., et al. Morphine inhibition of lymphocyte activity is mediated by an opioid dependent mechanism. Neuropharmacology 29 (1990) 369-374
98. Veyries M.L., Sinet M., Desforges B., et al. Effects of morphine on the pathogenesis of murine Friend retrovirus infection. J Pharmacol Exp Ther 272 (1995) 498-504
99. Hu S., Sheng W.S., Lokensgard J.R., et al. Morphine potentiates HIV-1 gp120-induced neuronal apoptosis. J Infect Dis 191 (2005) 886-889
100. West J.P., Dykstra L.A., and Lysle D.T. Immunomodulatory effects of morphine withdrawal in the rat are time dependent and reversible by clonidine. Psychopharmacology (Berl) 146 3 (1999) 320-327
101. Sacerdote P., Gaspani L., Rossoni G., et al. Effect of the opioid remifentanil on cellular immune response in the rat. Int Immunopharmacol 1 4 (2001) 713-719
102. Deng J., Muthu K., Gamelli R., et al. Adrenergic modulation of splenic macrophage cytokine release in polymicrobial sepsis. Am J Physiol Cell Physiol 287 3 (2004) C730-C736
103. Sternberg E.M. Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens. Nat Rev Immunol 6 4 (2006) 318-328
104. Oberbeck R., Schmitz D., Wilsenack K., et al. Adrenergic modulation of survival and cellular immune functions during polymicrobial sepsis. Neuroimmunomodulation 11 4 (2004) 214-223
105. Stevenson J.R., Westermann J., Liebmann P.M., et al. Prolonged alpha-adrenergic stimulation causes changes in leukocyte distribution and lymphocyte apoptosis in the rat. J Neuroimmunol 120 1-2 (2001) 50-57
106. Spengler R.N., Allen R.M., Remick D.G., et al. Stimulation of alpha-adrenergic receptor augments the production of macrophage-derived tumor necrosis factor. J Immunol 145 5 (1990) 1430-1434
107. Flierl M.A., Rittirsch D., Nadeau B.A., et al. Phagocyte-derived catecholamines enhance acute inflammatory injury. Nature 449 7163 (2007) 721-725
108. Memiş D., Hekimoǧlu S., Vatan I., et al. Effects of midazolam and dexmedetomidine on inflammatory responses and gastric intramucosal pH to sepsis, in critically ill patients. Br J Anaesth 98 (2007) 550-552
109. Venn R.M., Bryant A., Hall G.M., et al. Effects of dexmedetomidine on adrenocortical function, and the cardiovascular, endocrine and inflammatory responses in post-operative patients needing sedation in the intensive care unit. Br J Anaesth 86 (2001) 650-656
110. Nader N.D., Ignatowski T.A., Kurek C.J., et al. Clonidine suppresses plasma and cerebrospinal fluid concentrations of TNF-alpha during the perioperative period. Anesth Analg 93 (2001) 363-369
111. Weatherby K.E., Zwilling B.S., and Lafuse W.P. Resistance of macrophages to Mycobacterium avium is induced by alpha2-adrenergic stimulation. Infect Immun 71 (2003) 22-29
112. Miles B.A., Lafuse W.P., and Zwilling B.S. Binding of -adrenergic receptors stimulates the anti-mycobacterial activity of murine peritoneal macrophages. J Neuroimmunol 71 (1996) 19-24
113. Gets J., and Monroy F.P. Effects of alpha- and beta-adrenergic agonists on Toxoplasma gondii infection in murine macrophages. J Parasitol 91 1 (2005) 193-195
114. Tracey K.J. Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest 117 2 (2007) 289-296
115. Sud R., Spengler R.N., Nader N.D., et al. Antinociception occurs with a reversal in alpha 2-adrenoceptor regulation of TNF production by peripheral monocytes/macrophages from pro- to anti-inflammatory. Eur J Pharmacol 588 2-3 (2008) 217-231
116. Kang B.Y., Lee S.W., and Kim T.S. Stimulation of interleukin-12 production in mouse macrophages via activation of p38 mitogen-activated protein kinase by alpha2-adrenoceptor agonists. Eur J Pharmacol 467 1-3 (2003) 223-231
117. Yang C.L., Tsai P.S., and Huang C.J. Effects of dexmedetomidine on regulating pulmonary inflammation in a rat model of ventilator-induced lung injury. Acta Anaesthesiol Taiwan 46 4 (2008) 151-159
118. Nishina K., Akamatsu H., Mikawa K., et al. The effects of clonidine and dexmedetomidine on human neutrophil functions. Anesth Analg 88 2 (1999) 452-458
119. Bao J.Y., Huang Y., Wang F., et al. Expression of alpha-AR subtypes in T lymphocytes and role of the alpha-ARs in mediating modulation of T cell function. Neuroimmunomodulation 14 6 (2007) 344-353
120. Cook-Mills J.M., Cohen R.L., Perlman R.L., et al. Inhibition of lymphocyte activation by catecholamines: evidence for a non-classical mechanism of catecholamine action. Immunology 85 4 (1995) 544-549
121. von Dossow V., Baehr N., Moshirzadeh M., et al. Clonidine attenuated early proinflammatory response in T-cell subsets after cardiac surgery. Anesth Analg 103 4 (2006) 809-814
122. 2A-adrenoceptor subtype. Eur J Pharmacol 502 (2004) 87-97
123. Riker R.R., Shehabi Y., Bokesch P.M., et al. SEDCOM (Safety and Efficacy of Dexmedetomidine Compared With Midazolam) Study Group. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA 301 (2009) 489-499